Breakthrough Drugs for our Time
Agastiya Biotech merges advanced, Eastern knowledge with rigorous Western R&D in order to deliver breakthrough innovative pharmaceuticals to the marketplace. Over 40% of all pharmaceutical drugs, including sophisticated chemotherapy and anti-viral drugs, are derived from natural plant sources. Through investigation of ancient Eastern botanical knowledge combined with high throughput and AI driven analysis, Agastiya Biotech engineers best in class novel small molecules for treatment of disease.
We are leading the discovery and design of ground-breaking small molecules to revolutionize medicine and find a cure for the diseases of our time.
Prior to founding Agastiya Biotech, Dr. Baskaran Pillai started East West Integrative Research Institute in Chennai, India in 2013, which successfully created a psoriasis drug with over 300 case studies at a major medical institution (MMC) exclusively marketed by Lupin Pharmaceuticals in India.
Dr. Pillai’s vision for Agastiya Biotech is to create new medicine for the 21stcentury through an eclectic approach of ancient Indian medicine and Western biotech. His inventions include discovering unknown proteins from plants and chemicals through a combination of proteomics and the ancient Indian medical systems of Ayurveda and Siddha.
The Legend of Agasitya
Agastiya, the legendary Tamil and Vedic Siddha Master, is the foremost medicine man of Indian medicine. His knowledge of diseases, medicine and multiple (if not all) disciplines including the modern string theory about the creation of the primordial matter and energy is encyclopedic. His ultimate goal for medicine is akin to translating Einstein’s theory of interconnectivity of energy and matter through the transformation of the human flesh body into a light body. It is not an exaggeration to say that Agastiya is the master of all arts and sciences known as well as unknown (including the unknowable).
Nevertheless, there is a problem with Agastiya as well as his fellow Tamil Siddhas. They deliberately delude and misdirect the common reader and the non-initiates, not for patent protection or for profiteering, but for preventing misuse of divine knowledge by egocentric and greedy people.
A master of the Siddha tradition, Dr. Pillai is able to decode encrypted knowledge both of phytochemicals as well as natural occurring chemicals. He is considered a Siddha Master like Agastiya himself whose mission is to unlock the many mysteries. Practically speaking, compared to classical Agastiya, Dr. Pillai is situated in a better place time-wise living in the 21st Century with ultra-modern life sciences and technologies.
Dr. Pillai is an authority in Siddha medicine. He hosted the first Siddha medicine conference dedicated to new discoveries in 1990. He has passionately pursued both the science and cosmology of herbs, and facilitates collaboration between Western learning institutes and Indian growers regarding best practices for quality assurance and safety.
Dr. Pillai has been a speaker for the United Nations Conference of World Religions and the World Knowledge Forum, and has hosted forums on Religion and Science. His scholarly background includes a Masters Degree in English Literature and Comparative Literature from Madurai University and a PhD in Religious Studies from the University of Pittsburgh where he was both a teaching fellow in the Department of Religious Studies and Coordinator of Indian Studies program for the Department of International Studies.
Dr. Pillai is a scholar, philanthropist, global educator, and an international leader dedicated to helping all people reach their highest potentials. He is a progressive and innovative thought leader in the field of self-advancement knowledge and practices. Millions of people have experienced significant improvements in their lives as a result of the teachings and programs. Dr. Pillai shares across multiple platforms including YouTube, Facebook, virtual learning web sites and in-person workshops and retreats.
Heading Agastiya Biotech’s cancer stem cell research, Dr. Dinesh holds a PhD in Stem Cell Biology from Sri Ramachandra University in Chennai. He has over 12 years in dedicated stem cell research and drug discovery with many premier institutions resulting in dozens of international and national publications and several patents. Dr. Dinesh conducted a single-arm, open-labeled clinical study with chronic plaque psoriasis patients, in which he also involved in dose preparation, safety, validation and efficacy studies, resulting in the launch of a chronic plaque psoriasis product sold to Lupin Pharmaceuticals.